Skip to main content
. 2022 Dec 10;21:279. doi: 10.1186/s12933-022-01713-3

Table 2.

Initiation rates and initiation rate ratios for female and male patients

Persons Individuals
initiating GLD
Person Years (PY) Initiation rate
(per 1000 PY)
Crude initiation rate ratio (95% CI) Adjusted 1 initiation rate ratio
(95% CI)
Adjusted 2 initiation rate ratio
(95% CI)
Cardiovascular disease
 Male 41,333 4261 113,195 37.64 (36.53–38.79)
 Female 25,949 2015 70,061 28.76 (27.53–30.04) 0.76 (0.72–0.81) 0.86 (0.82–0.91) 0.92 (0.87–0.97)
Ischemic heart disease
 Male 21,416 2558 62,405 40.99 (9.43–42.61) - -
 Female 11,530 1092 34,429 31.72 (29.89–33.66) 0.77 (0.72–0.83) 0.85 (0.79–0.91) 0.91 (0.85–0.98)
Heart failure
 Male 6137 592 14,441 41.00 (37.82–44.43)
 Female 4305 258 9772 26.40 (23.37–29.83) 0.64 (0.56–0.75) 0.81 (0.70–0.94) 0.85 (0.73–1.00)a
Peripheral arterial disease
 Male 4813 421 12,827 32.82 (29.83–36.11)
 Female 3247 218 8663 25.16 (22.04–28.73) 0.77 (0.65–0.90) 0.88 (0.75–1.04) 0.92 (0.78–1.09)
Stroke
 Male 8967 690 23,522 29.33 (27.22–31.61)
 Female 6867 447 17,196 25.99 (23.69–28.52) 0.89 (0.79–1.00) 0.97 (0.86–1.10) 1.06 (0.93–1.20)

Adjustment 1: Age at dual diagnosis, diabetes duration, calendar year and educational level

Adjustment 2: adjustment 1 + HbA1c, LDL, eGFR, lipid lowering medication, and antihypertensive medication

HbA1c Hemoglobin A1c; LDL low-density lipoprotein cholesterol; GFR glomerular filtration rate

aUpper limit of 95% confidence interval < 1.00